133 related articles for article (PubMed ID: 17196514)
1. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.
Bader AA; Schlembach D; Tamussino KF; Pristauz G; Petru E
Lancet Oncol; 2007 Jan; 8(1):79-81. PubMed ID: 17196514
[No Abstract] [Full Text] [Related]
2. Trastuzumab use for metastatic breast cancer in pregnancy.
Sekar R; Stone PR
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):507-10. PubMed ID: 17666645
[TBL] [Abstract][Full Text] [Related]
3. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios.
Watson WJ
Obstet Gynecol; 2005 Mar; 105(3):642-3. PubMed ID: 15738038
[TBL] [Abstract][Full Text] [Related]
4. Herceptin therapy in pregnancy: continuation of pregnancy in the presence of anhydramnios.
Warraich Q; Smith N
J Obstet Gynaecol; 2009 Feb; 29(2):147-8. PubMed ID: 19274553
[No Abstract] [Full Text] [Related]
5. Use of pertuzumab and trastuzumab during pregnancy.
Yildirim N; Bahceci A
Anticancer Drugs; 2018 Sep; 29(8):810-813. PubMed ID: 30110018
[TBL] [Abstract][Full Text] [Related]
6. Emerging therapeutic options for breast cancer chemotherapy during pregnancy.
Mir O; Berveiller P; Ropert S; Goffinet F; Pons G; Treluyer JM; Goldwasser F
Ann Oncol; 2008 Apr; 19(4):607-13. PubMed ID: 17921242
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab in pregnancy associated with poor fetal outcome.
Witzel ID; Müller V; Harps E; Janicke F; Dewit M
Ann Oncol; 2008 Jan; 19(1):191-2. PubMed ID: 18084047
[No Abstract] [Full Text] [Related]
8. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios.
Beale JM; Tuohy J; McDowell SJ
Am J Obstet Gynecol; 2009 Jul; 201(1):e13-4. PubMed ID: 19398090
[TBL] [Abstract][Full Text] [Related]
9. Treatment of breast cancer with trastuzumab during pregnancy.
Pant S; Landon MB; Blumenfeld M; Farrar W; Shapiro CL
J Clin Oncol; 2008 Mar; 26(9):1567-9. PubMed ID: 18349415
[No Abstract] [Full Text] [Related]
10. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy.
Fanale MA; Uyei AR; Theriault RL; Adam K; Thompson RA
Clin Breast Cancer; 2005 Oct; 6(4):354-6. PubMed ID: 16277887
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy.
Chen JH; Mehta RS; Carpenter PM; Nalcioglu O; Su MY
J Clin Oncol; 2007 Dec; 25(35):5667-9. PubMed ID: 18065744
[No Abstract] [Full Text] [Related]
12. Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy.
Shieh MP; Mehta RS
Ann Oncol; 2011 Sep; 22(9):2151-2152. PubMed ID: 21799203
[No Abstract] [Full Text] [Related]
13. Trastuzumab combined with paclitaxel after doxorubicin and cyclophosphamide for operable HER2-positive breast cancer.
Ferretti G; Felici A; Papaldo P; Carlini P; Fabi A; Cognetti F
Oncologist; 2006 May; 11(5):533; author reply 534. PubMed ID: 16720857
[No Abstract] [Full Text] [Related]
14. Trastuzumab administration during pregnancy: an update.
Andrikopoulou A; Apostolidou K; Chatzinikolaou S; Bletsa G; Zografos E; Dimopoulos MA; Zagouri F
BMC Cancer; 2021 Apr; 21(1):463. PubMed ID: 33902516
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.
Seidman AD; Berry D; Cirrincione C; Harris L; Muss H; Marcom PK; Gipson G; Burstein H; Lake D; Shapiro CL; Ungaro P; Norton L; Winer E; Hudis C
J Clin Oncol; 2008 Apr; 26(10):1642-9. PubMed ID: 18375893
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab in metastatic breast cancer.
Mirtsching B; Cosgriff T; Harker G; Keaton M; Chidiac T; Min M
Clin Breast Cancer; 2011 Apr; 11(2):121-8. PubMed ID: 21569998
[TBL] [Abstract][Full Text] [Related]
17. Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer.
Fornier M; Esteva FJ; Seidman AD
Semin Oncol; 2000 Dec; 27(6 Suppl 11):38-45; discussion 92-100. PubMed ID: 11236027
[TBL] [Abstract][Full Text] [Related]
18. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer.
Abusief ME; Missmer SA; Ginsburg ES; Weeks JC; Partridge AH
Cancer; 2010 Feb; 116(4):791-8. PubMed ID: 20052714
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer.
Burris H; Yardley D; Jones S; Houston G; Broome C; Thompson D; Greco FA; White M; Hainsworth J
J Clin Oncol; 2004 May; 22(9):1621-9. PubMed ID: 15117984
[TBL] [Abstract][Full Text] [Related]
20. A case study of trastuzumab treatment for metastatic breast cancer in pregnancy: fetal risks and management of cerebral metastases.
Mandrawa CL; Stewart J; Fabinyi GC; Walker SP
Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):372-6. PubMed ID: 21806575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
